Opening of neuronal K+ channels by flupirtine;Neuronale kaliumkanaloffnung durch flupirtin

Fortschritte der Neurologie Psychiatrie

Volumn 67, Issue 10, 1999, Pages 466-475

  Kornhuber, J ^a   Maler, M ^b   Wiltfang, J ^b   Bleich, S ^b   Degner, D ^b   Ruther E ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUPIRTINE; GUANINE NUCLEOTIDE BINDING PROTEIN; N METHYL DEXTRO ASPARTIC ACID; POTASSIUM CHANNEL; AMINOPYRIDINE DERIVATIVE; NEUROPROTECTIVE AGENT;

ANALGESIC ACTIVITY; ARTICLE; CHANNEL GATING; CONCENTRATION RESPONSE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; MUSCLE RELAXATION; NERVE FIBER MEMBRANE STEADY POTENTIAL; NEUROPROTECTION; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; HUMAN; METABOLISM; NERVE CELL; REVIEW;

AMINOPYRIDINES; ANIMALS; HUMANS; NEURONS; NEUROPROTECTIVE AGENTS; POTASSIUM CHANNELS;

EID: 0032708985     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994997     Document Type: Article

References (84)

1. Abele AE, Miller RJ. Potassium channel activators abolish excitotoxicity in cultured hippocampal pyramidal neurons. Neurosci Lett 1990; 115: 195-200
2. Abrams SML, Baker LRI, Crome P, White AST, Johnston A, Ankier SI, Warrington SJ, Turner P, Niebch G. Pharmacokinetics of flupirtine in elderly volunteers and in patients with moderate renal impairment. Postgrad Med J 1988; 64: 361-363
3. Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984; 7: 309-338
4. + channels reduce anoxic depolarization in CA3 hippocampal neurons. Neuroscience 1990; 37: 55-60
5. Bleyer H, Carlsson KH, Erkel HJ, Jurna I. Flupirtine depresses nociceptive activity evoked in rat thalamus. Eur J Pharmacol 1988; 151: 259-265
6. Block F, Pergande G, Schwarz M. Flupirtine protects against ischaemic retinal dysfunction in rats. NeuroReport 1994; 5: 2630-2632
7. Block F, Pergande G, Schwarz M. Flupirtine reduces functional deficits and neuronal damage after global ischemia in rats. Brain Res 1997; 754: 279-284
8. Brune K. Pharmacology of centrally acting analgesics: an introduction. Postgrad Med J 1987; 63 Suppl 3: 5-7
9. Carlsson KH, Jurna I. Depression by flupirtine, a novel analgesic agent, of motor and sensory responses of the nociceptive system in the rat spinal cord. Eur J Pharmacol 1987; 143: 89-99
10. Darius H, Schrör K. The action of flupirtine on prostaglandin formation and platelet aggregation in vitro. Arzneimittelforschung 1985; 35: 55-59
11. Del Pozo E, Barrios M, Baeyens JM. Effects of potassium channel openers on pentylenetetrazole-induced seizures in mice. Pharmacol Toxicol 1990; 67: 182-184
12. Engel J. Flupirtine - a new centrally acting analgesic with unique chemical structure. Postgrad Med J 1987; 63 Suppl 3: 15-17
13. Friedel HA, Fitton A. Flupirtine: a review of its pharmacological properties and therapeutic efficacy in pain states. Drugs 1993; 45: 548-569
14. + channel openers decrease seizures in genetically epileptic rats. Eur J Pharmacol 1989; 167: 181-183
15. + channel openers protect hippocampal neurons against oxidative injury and amyloid β-peptide toxicity. Brain Res 1996; 706: 328-332
16. Hayes AG, Skingle M, Tyers MB. Alpha-adrenoceptor-mediated antinociception and sedation in the rat and dog. Neuropharmacology 1986; 25: 391-396
17. + channel openers prevent global ischaemia-induced expression of c-fos, c-jun, heat-shock protein and amyloid β-protein precursor genes and neuronal death in rat hippocampus. Proc Natl Acad Sci USA 1993; 90: 9431-9435
18. Hlavica P, Niebch G. Untersuchungen zur Pharmakokinetik und Biotransformation des Analgetikums Flupirtin beim Menschen. Arzneimittelforschung 1985; 35: 67-74
19. Ho K, Nichols CG, Lederer WJ, Lytton J, Vassilev PM, Kanazirska MV, Hebert SC. Cloning and expression of an inwardly rectifying ATP-regulated potassium channel. Nature 1993; 362: 31-38
20. Hummel T, Friedmann T, Pauli E, Niebch G, Borbe HO, Kobal G. Dose-related analgesic effects of flupirtine. Br J Clin Pharmacol 1991; 32: 69-76
21. Isomoto S, Kondo C, Kurachi Y. Inwardly rectifying potassium channels: their molecular heterogeneity and function. Jpn J Physiol 1997; 47: 11-39
22. Jakob R, Krieglstein J. Influence of flupirtine on a G-protein coupled inwardly rectifying potassium current in hippocampal neurones. Br J Pharmacol 1997; 122: 1333-1338
23. Jakovlev V, Sofia RD, Achterrath-Tuckermann U, Schlichtegroll von A, Thiemer K. Untersuchungen zur pharmakologischen Wirkung von Flupirtin, einem strukturell neuartigen Analgetikum. Arzneimittelforschung 1985; 35: 30-43
24. Karschin A, Wischmeyer E, Döring F, Karschin C. Kalium-Einwärtsgleichrichter - ursprüngliche Kanalstrukturen als Basis funktioneller Varianten. Neuroforum 1997; 4: 127-132
25. + channel mRNAs are differentially expressed in the adult rat brain. J Neurosci 1996; 16: 3559-3570
26. + channel in the rat. FEBS Lett 1994; 348: 139-144
27. + channel (mGIRK1) and distinct distributions of three GIRK (GIRK1, 2 and 3) mRNAs in mouse brain. Biochem Biophys Res Commun 1995; 208: 1166-1173
28. Kornhuber J, Quack G, Danysz W, Jellinger K, Danielczyk W, Gsell W, Riederer P. Therapeutic brain concentration of the NMDA receptor antagonist amantadine. Neuropharmacology 1995; 34: 713-721
29. Kornhuber J, Schultz A, Wiltfang J, Meineke I, Gleiter CH, Zöchling R, Boissl KW, Leblhuber F, Riederer P. Persistence of haloperidol in human brain tissue. Am J Psychiatry; 1999. 56: 885-890
30. Kubo Y, Reuveny E, Slesinger PA, Jan YN, Jan LY. Primary structure and functional expression of a rat G-protein-coupled muscarinic potassium channel. Nature 1993; 364: 802-806
31. Lauritzen I, Weille De JR, Lazdunski M. The potassium channel opener (-)-cromakalim prevents glutamate-induced cell death in hippocampal neurons. J Neurochem 1997; 69: 1570-1579
32. Mattia D, Nagao T, Rogawski MA, Avoli M. Potassium channel activators counteract anoxic hyperexcitability but not 4-amino-pyridine-induced epileptiform activity in the rat hippocampal slice. Neuropharmacology 1994; 33: 1515-1522
33. Million R, Finlay BR, Whittington JR. Clinical trial of flupirtine in the patients with migraine. Curr Med Res Opin 1984; 9: 204-212
34. Moore R, Bullingham RES, Simpson S, O'Sullivan G, Evans PJD, McQuay J. Comparison of flupirtine maleate and dihydrocodeine in patients following surgery. Br J Anaesth 1983; 55: 429-432
35. Müller WEG, Dobmeyer JM, Dobmeyer TS, Pergande G, Perovic S, Leuck J, Rossol R. Flupirtine protects both neuronal cells and lymphocytes against induced apoptosis in vitro: implications for treatment of AIDS patients. Cell Death Differ 1997; 4: 51-58
36. Müller WEG, Romero FJ, Perovic S, Pergande G, Pialoglou P. Protection of flupirtine on β-amyloid-induced apoptosis in neuronal cells in vitro: prevention of amyloid-induced glutathione depletion. J Neurochem 1997; 68: 2371-2377
37. Nickel B. The antinociceptive activity of flupirtine: a structurally new analgesic. Postgrad Med J 1987; 63 Suppl 3: 19-28
38. Nickel B, Aledter A. Comparative physical dependence studies in rats with flupirtine and opiate receptor stimulating analgesics. Postgrad Med J 1987; 63 Suppl 3: 41-43
39. Nickel B, Borbe HO, Szelenyi I. Investigations with the novel non-opioid analgesic flupirtine in regard to possible benzodiazepine-like abuse inducing potential. Arzneimittelforschung 1990; 40: 905-908
40. Nickel B, Engel J, Szelenyi I. Possible involvement of noradrenergic descending pain-modulating pathways in the mode of antinociceptive action of flupirtine, a novel non-opioid analgesic. Agents Actions 1988; 23: 112-116
41. Nickel B, Herz A, Jakovlev V, Tiebes U. Untersuchungen zum Wirkungsmechanismus des Analgetikums Flupirtin. Arzneimittelforschung 1985; 35: 1402-1409
42. Nickel B, Jakovlev V, Szelenyi I. Einfluß von Flupirtin, verschiedenen Analgetika und Muskelrelaxantien auf den Skelettmuskeltonus wacher Ratten. Arzneimittelforschung 1990; 40: 909-911
43. Niebch G, Borbe HO, Hummel T, Kobal G. Dose-proportional plasma levels of the analgesic flupirtine maleate in man. Application of a new HPLC assay. Arzneimittelforschung 1992; 42: 1343-1345
44. North RA. Drug receptors and the inhibition of nerve cells. Br J Pharmacol 1989; 98: 13-28
45. Obermeier K, Niebch G, Thiemer K. Untersuchungen zur Pharmakokinetik und Biotransformation des Analgetikums Flupirtin bei Ratte und Hund. Arzneimittelforschung 1985; 35: 60-67
46. B and κ-opioid receptor agonists. Br J Pharmacol 1993; 110: 1049-1054
47. B, mu and kappa opioid receptors. J Pharmacol Exp Ther 1996; 276: 1136-1142
48. Ocaña M, Del Pozo E, Barrios M, Robles LI, Baeyens JM. An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur J Pharmacol 1990; 186: 377-378
49. + channel blockers antagonize morphine-but not U-504 88H-induced antinociception. Eur J Pharmacol 1993; 230: 203-207
50. Osborne NN, Cazevieille C, Wood JPM, Nash MS, Pergande G, Block F, Kosinski C, Schwarz M. Flupirtine, a nonopioid centrally acting analgesic, acts as a NMDA antagonist. Gen Pharmacol 1998; 30: 255-263
51. Osborne NN, Schwarz M, Pergande G. Protection of rabbit retina from ischemic injury by flupirtine. Invest Ophthalmol Vis Sci 1996; 37: 274-280
52. Patil N, Cox DR, Bhat D, Faham M, Myers RM, Peterson AS. A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nat Genet 1995; 11: 126-129
53. Perovic S, Pergande G, Ushijima H, Kelve M, Forrest J, Müller WEG. Flupirtine partially prevents neuronal injury induced by prion protein fragment and lead acetate. Neurodegeneration 1995; 4: 369-374
54. Perovic S, Pialoglou P, Schröder HC, Pergande G, Müller WEG. Flupirtine increases the levels of glutathione and Bcl-2 in hNT (human Ntera/D1) neurons: mode of action of the drug-mediated anti-apoptotic effect. Eur J Phamacol 1996; 317: 157-164
55. Perovic S, Schleger C, Pergande G, Iskric I, Ushijima H, Rytic P, Müller WEG. The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-methyl-D-aspartate and gp120 of HIV-1. Eur J Pharmacol 1994; 288: 27-33
56. Popoli P, Pezzola A, Sagratella S, Zeng YC, Scotti de Carolis A. Cromakalim (BRL 34915) counteracts the epileptiform activity elicited by diltiazem and verapamil in rats. Br J Pharmacol 1991; 104: 907-913
57. Porter AJ, Gratz E, Narang PK, Mirsky AE, Schwerdt P, Seaman CA, Smallberg S, Theodore W, Weingartner H, White BG. Effect of flupirtine on uncontrolled partial or absence seizures. Epilepsia 1983; 24: 253-254
58. Powell-Jackson P, Williams R. Use of flupirtine maleate as an analgesic in patients with liver disease. Br J Clin Pract 1985; 39: 63-66
59. 1A receptors. Eur J Pharmacol 1996; 295: 181-188
60. 2+ concentration. Eur J Pharmacol 1995; 294: 469-473
61. Schmidt WJ, Schuster G, Wacker E, Pergande G. Antiparkinsonian and other motor effects of flupirtine alone and in combination with dopaminergic drugs. Eur J Pharmacol 1997; 327: 1-9
62. Schuster G, Schwarz M, Block F, Pergande G, Schmidt WJ. Flupirtine: a review of its neuroprotective and behavioral properties. CNS Drugs (im Druck); 1999
63. Schwarz M, Block F, Pergande G. N-methyl-D-aspartate (NMDA)-mediated muscle relaxant action on flupirtine in rats. NeuroReport 1994; 5: 1981-1984
64. Schwarz M, Nolden-Koch M, Purr J, Pergande G, Block F. Antiparkinsonian effect of flupirtine in monoamine-depleted rats. J Neural Transm 1996; 103: 581-590
65. 2-adrenergic mechanisms are involved in the depressant action of flupirtine on spinal reflexes in rats. Eur J Pharmacol 1995; 276: 247-255
66. Sheridan PH, Seaman CA, Narang PK, White BG, Schwerdt P, Theodore WH, Rose DF, Nice FJ, Gallelli JF, Mirsky AF, Engel J, Porter RJ. Pilot study of flupirtine in refractory seizures. Neuroloy 1986; 36 Suppl 1: 85
67. Shewade DG, Ramaswamy S. Prolactin induced analgesia is dependent on ATP sensitive potassium channels. Clin Exp Pharmacol Physiol 1995; 22: 635-636
68. + channels. Neuron 1996; 16: 321-331
69. Smeyne RJ, Goldowitz D. Development and death of external granular layer cells in the weaver mouse cerebellum: a quantitative study. J Neurosci 1989; 9: 1608-1620
70. Sofia RD, Diamantis W, Gordon R. Abuse potential and physical dependence liability studies with flupirtine maleate in laboratory animals. Postgrad Med J 1987; 63 Suppl 3: 35-40
71. Stanfield PR, Nakajima Y, Yamaguchi K. Substance P raises neuronal membrane excitability by reducing inward rectification. Nature 1985; 315: 498-501
72. Swedberg MD, Shannon HE, Nickel B, Goldberg SR. Pharmacological mechanisms of action of flupirtine: a novel, centrally acting, nonopioid analgesic evaluated by its discriminative effects in the rat. J Pharmacol Exp Ther 1988; 246: 1067-1074
73. Szelenyi I, Nickel B. Putative site(s) and mechanism(s) of action of flupirtine, a novel analgesic compound. Postgrad Med J 1987; 63 Suppl 3: 57-60
74. Szelenyi I, Nickel B, Borbe HO, Brune K. Mode of antinociceptive action of flupirtine in the rat. Br J Pharmacol 1989; 97: 835-842
75. Takano K, Stanfield PR, Nakajima S, Nakajima Y. Protein kinase C-mediated inhibition of an inward rectifier potassium channel by substance P in nucleus basalis neurons. Neuron 1995; 14: 999-1008
76. Vaupel DB, Nickel B, Becketts K. Flupirtine antinociception in the dog is primarily mediated by nonopioid supraspinal mechanisms. Eur J Pharmacol 1989; 162: 447-456
77. Vergoni AV, Scarano A, Bertolini A. Pinacidil potentiates morphine analgesia. Life Sci 1992; 50: L135-L138
78. Weiser T, Nickel B, Szelenyi I, Wienrich M. In vivo and in vitro findings about the muscle relaxing properties of flupirtine. Naunyn-Schmiedeberg's Arch Pharmacol 1992; 346 Suppl 1: R22
79. Welch SP, Dunlow LD. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action. J Pharmacol Exp Ther 1993; 267: 390-399
80. Wild KD, Vanderah T, Mosberg HI, Porreca F. Opioid δ receptor subtypes are associated with different potassium channels (published erratum: Eur J Pharmacol 1991 195:415). Eur J Pharmacol 1991; 193: 135-136
81. Wörz R. Flupirtin - Zentral wirkendes Analgetikum und Muskelrelaxans ohne Abhängigkeitspotential. Arzneimitteltherapie 1998; 16: 134-136
82. Yamaguchi K, Nakajima Y, Nakajima S, Stanfield PR. Modulation of inwardly rectifying channels by substance P in cholinergic neurones from rat brain in culture (published erratum: J Physiol (Lond) 1991 432:709-10). J Physiol Lond 1990; 426: 499-520
83. Zimmer G, Balakirev M, Zwicker K, Hofmann M, Woodcock BG, Pergande G. Effect of the triaminopyridine flupirtine on calcium uptake, membrane potential and ATP synthesis in rat heart mitochondria. Br J Pharmacol 1998; 123: 1154-1158
84. Zini S, Roisin MP, Armengaud C, Ben-Ari Y. Effect of potassium channel modulators on the release of glutamate induced by ischaemic-like conditions in rat hippocampal slices. Neurosci Lett 1993; 153: 202-205